Roche, Galenica deal

Roche granted Galenica exclusive, U.S. commercialization rights to Mircera methoxy polyethylene glycol-epoetin beta. Roche will manufacture and supply Mircera to Galenica. Roche will receive an upfront payment and supply reimbursements and is eligible for milestones and tiered royalties. Roche declined to disclose financial terms, and Galenica could not be reached. ...